SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095401
Filing Date
2024-08-12
Accepted
2024-08-12 16:05:21
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20240630.htm   iXBRL 10-Q 2201618
2 EX-31.1 annx-ex31_1.htm EX-31.1 16160
3 EX-31.2 annx-ex31_2.htm EX-31.2 15665
4 EX-32.1 annx-ex32_1.htm EX-32.1 13777
  Complete submission text file 0000950170-24-095401.txt   7419635

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT annx-20240630.xsd EX-101.SCH 946374
60 EXTRACTED XBRL INSTANCE DOCUMENT annx-20240630_htm.xml XML 1163205
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 241196727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)